Actual versus Predicted Overall Survival in Patients Treated Surgically for Metastatic Spinal Cord Compression
Medical Forum Monthly · 01.07.2026 · 37 (6)
DOI: 10.60110/medforum.370606 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Forum Monthly, online erschienen am 01.07.2026. Verfasst von Zaid Sami Ullah und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To compare the predicted survivals based on Tokuhashi and Tomita scores, as well as clinical estimates by the oncologist, with the actual observed survival Study Design: A retrospective observational studyPlace and Duration of Study: This study was conducted at the Queen Elizabeth Hospital, Birmingham, UK between 20th June 2025 to 19th October 2025.
Methods
This was a retrospective observational study was carried out at Queen Elizabeth Hospital, Birmingham, UK between 20th June 2025 to 19th October 2025 of 32 patients treated surgically for metastatic spinal cord compression.
Results
A Cox proportional hazards model found Tokuhashi and Tomita scores to have negative predictive values. Log-rank tests demonstrated p-values
Zitieren
APA
Ullah, Z. S., Bates, O., Wongkalasin, N., Dhir, J., & Czyz, M. (2026). Actual versus Predicted Overall Survival in Patients Treated Surgically for Metastatic Spinal Cord Compression. Medical Forum Monthly, 37(6). https://doi.org/10.60110/medforum.370606
Vancouver
Ullah ZS, Bates O, Wongkalasin N, Dhir J, Czyz M. Actual versus Predicted Overall Survival in Patients Treated Surgically for Metastatic Spinal Cord Compression. Medical Forum Monthly. 2026;37(6). doi:10.60110/medforum.370606
BibTeX
@article{Ullah2026,
author = {Ullah, Zaid Sami and Bates, Oliver and Wongkalasin, Namwa and Dhir, Jasmeet and Czyz, Marcin},
title = {Actual versus Predicted Overall Survival in Patients Treated Surgically for Metastatic Spinal Cord Compression},
journal = {Medical Forum Monthly},
year = {2026},
volume = {37},
number = {6},
doi = {10.60110/medforum.370606}
}
EUVIMED